Dianthus Therapeutics (DNTH) Change in Acquisitions & Divestments (2019 - 2025)

Dianthus Therapeutics has reported Change in Acquisitions & Divestments over the past 6 years, most recently at $78.6 million for Q3 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $78.6 million for Q3 2025, up 313.53% from a year ago — trailing twelve months through Sep 2025 was $305.3 million (up 408.86% YoY), and the annual figure for FY2024 was $127.0 million, up 63.27%.
  • Change in Acquisitions & Divestments for Q3 2025 was $78.6 million at Dianthus Therapeutics, up from $59.6 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for DNTH hit a ceiling of $85.0 million in Q4 2024 and a floor of $2.0 million in Q4 2022.
  • Median Change in Acquisitions & Divestments over the past 4 years was $20.4 million (2023), compared with a mean of $35.6 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 800.0% in 2023 and later plummeted 63.45% in 2024.
  • Dianthus Therapeutics' Change in Acquisitions & Divestments stood at $2.0 million in 2022, then skyrocketed by 800.0% to $18.0 million in 2023, then soared by 372.22% to $85.0 million in 2024, then decreased by 7.56% to $78.6 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $78.6 million (Q3 2025), $59.6 million (Q2 2025), and $82.1 million (Q1 2025) per Business Quant data.